The Global Drug Facility (GDF) is a key mechanism of the Stop TB Partnership that offers nations a full range of high quality drugs and diagnostic tools at reasonable prices. This is leading the way to a world without tuberculosis, a disease that is curable but still kills three people every minute.
Today, in resource-limited settings, TB is primarily diagnosed by sputum smear microscopy as more sensitive methods are often not available particularly due to the lack of infrastructure, skilled personnel and financing.
The TB-LAMP solution, developed by our partner Eiken Chemicals Co., Ltd., is a molecular method for the detection of Mycobacterium Tuberculosis Complex. Its robustness, high sensitivity and ease of use makes LAMP an excellent and nearly failsafe solution to improve TB diagnostics in remote areas. Moreover, this system offers a higher throughput of samples in lesser time than existing technologies. In 2016, WHO recommended that smear microscopy may be replaced by TB-LAMP (http://sho.rtlink.de/lamp).
Due to the inclusion of HUMAN’s TB-LAMP products, countries will get better access to sensitive TB diagnostics and support in their engagement to end TB.
For more information about TB-LAMP visit us at www.human.de/lamp.
* Publishing of the TB-LAMP products in the GDF online catalog is foreseen in Q1 2018.
About Stop TB: http://www.stoptb.org/about/
WHO recommendation TB-LAMP: www.who.int/tb/features_archive/TB_LAMP/en/
Company Information EIKEN, FIND, HUMAN
HUMAN, founded in 1972, is a Germany based privately owned company which develops, manufactures and distributes a wide range of IVD Diagnostics and laboratory equipment. The comprehensive portfolio of more than 400 products covers almost all areas of modern laboratory including Autoimmune and Molecular Diagnostics. With its strong network of partners in 160 countries and with six regional offices around the globe, HUMAN maintains probably the broadest distribution and service network, especially in developing and emerging countries.
Janina Klein, Marketing Communications
EIKEN CHEMICAL Co., Ltd. was established in 1939 and was the first Japanese company to successfully commercialize the manufacture of powdered culture media for microbiological investigations. The company has established itself as a leader in the clinical diagnostics market, and has a strong commitment to research and development toward global products and technologies that fulfill needs at the cutting edge of contemporary medicine. The LAMP technology, developed at EIKEN in 1998, is now a core technology being exploited to develop a range of products.
Contact EIKEN CHEMICAL Co., Ltd.:
Public Relations Department